202 related articles for article (PubMed ID: 9477479)
1. Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens.
Lobato ZI; Coupar BE; Gray CP; Lunt R; Andrew ME
Vet Immunol Immunopathol; 1997 Nov; 59(3-4):293-309. PubMed ID: 9477479
[TBL] [Abstract][Full Text] [Related]
2. DNA vaccine prime and recombinant FPV vaccine boost: an important candidate immunization strategy to control bluetongue virus type 1.
Li J; Yang T; Xu Q; Sun E; Feng Y; Lv S; Zhang Q; Wang H; Wu D
Appl Microbiol Biotechnol; 2015 Oct; 99(20):8643-52. PubMed ID: 26048472
[TBL] [Abstract][Full Text] [Related]
3. Genetically engineered multi-component virus-like particles as veterinary vaccines.
Pearson LD; Roy P
Immunol Cell Biol; 1993 Oct; 71 ( Pt 5)():381-9. PubMed ID: 8270267
[TBL] [Abstract][Full Text] [Related]
4. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.
Stewart M; Dovas CI; Chatzinasiou E; Athmaram TN; Papanastassopoulou M; Papadopoulos O; Roy P
Vaccine; 2012 Mar; 30(12):2131-9. PubMed ID: 22285887
[TBL] [Abstract][Full Text] [Related]
5. Application of bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2.
Feenstra F; Pap JS; van Rijn PA
Vaccine; 2015 Feb; 33(6):812-8. PubMed ID: 25510389
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the immune response afforded by a subunit vaccine candidate against bluetongue virus in mice and sheep.
Mohamed DKA; Du J; Gao S; Tian Z; Zhang G; Huang D; Du R; Kang B; Liu G; Luo J; Yin H
Vet Microbiol; 2018 Jun; 219():40-48. PubMed ID: 29778203
[TBL] [Abstract][Full Text] [Related]
7. Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(-/-) mice against lethal bluetongue infection.
Calvo-Pinilla E; Rodríguez-Calvo T; Sevilla N; Ortego J
Vaccine; 2009 Dec; 28(2):437-45. PubMed ID: 19857449
[TBL] [Abstract][Full Text] [Related]
8. Vesicular stomatitis virus replicon expressing the VP2 outer capsid protein of bluetongue virus serotype 8 induces complete protection of sheep against challenge infection.
Kochinger S; Renevey N; Hofmann MA; Zimmer G
Vet Res; 2014 Jun; 45(1):64. PubMed ID: 24928313
[TBL] [Abstract][Full Text] [Related]
9. Topography and immunogenicity of bluetongue virus VP7 epitopes.
Wang LF; Hyatt AD; Whiteley PL; Andrew M; Li JK; Eaton BT
Arch Virol; 1996; 141(1):111-23. PubMed ID: 8629938
[TBL] [Abstract][Full Text] [Related]
10. Expression of VP7, a Bluetongue virus group specific antigen by viral vectors: analysis of the induced immune responses and evaluation of protective potential in sheep.
Bouet-Cararo C; Contreras V; Caruso A; Top S; Szelechowski M; Bergeron C; Viarouge C; Desprat A; Relmy A; Guibert JM; Dubois E; Thiery R; Bréard E; Bertagnoli S; Richardson J; Foucras G; Meyer G; Schwartz-Cornil I; Zientara S; Klonjkowski B
PLoS One; 2014; 9(11):e111605. PubMed ID: 25364822
[TBL] [Abstract][Full Text] [Related]
11. Myxomavirus as a vector for the immunisation of sheep: protection study against challenge with bluetongue virus.
Top S; Foucras G; Deplanche M; Rives G; Calvalido J; Comtet L; Bertagnoli S; Meyer G
Vaccine; 2012 Feb; 30(9):1609-16. PubMed ID: 22244980
[TBL] [Abstract][Full Text] [Related]
12. Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep.
Boone JD; Balasuriya UB; Karaca K; Audonnet JC; Yao J; He L; Nordgren R; Monaco F; Savini G; Gardner IA; Maclachlan NJ
Vaccine; 2007 Jan; 25(4):672-8. PubMed ID: 17059856
[TBL] [Abstract][Full Text] [Related]
13. Antigen specificity of the ovine cytotoxic T lymphocyte response to bluetongue virus.
Andrew M; Whiteley P; Janardhana V; Lobato Z; Gould A; Coupar B
Vet Immunol Immunopathol; 1995 Aug; 47(3-4):311-22. PubMed ID: 8571549
[TBL] [Abstract][Full Text] [Related]
14. Recombinant virus vaccine for bluetongue disease in sheep.
Roy P; Urakawa T; Van Dijk AA; Erasmus BJ
J Virol; 1990 May; 64(5):1998-2003. PubMed ID: 2157868
[TBL] [Abstract][Full Text] [Related]
15. Recombinant Rift Valley fever viruses encoding bluetongue virus (BTV) antigens: Immunity and efficacy studies upon a BTV-4 challenge.
Moreno S; Calvo-Pinilla E; Devignot S; Weber F; Ortego J; Brun A
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008942. PubMed ID: 33275608
[TBL] [Abstract][Full Text] [Related]
16. VP2, VP7, and NS1 proteins of bluetongue virus targeted in avian reovirus muNS-Mi microspheres elicit a protective immune response in IFNAR(-/-) mice.
Marín-López A; Otero-Romero I; de la Poza F; Menaya-Vargas R; Calvo-Pinilla E; Benavente J; Martínez-Costas JM; Ortego J
Antiviral Res; 2014 Oct; 110():42-51. PubMed ID: 25057758
[TBL] [Abstract][Full Text] [Related]
17. Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell Responses.
Martín V; Pascual E; Avia M; Peña L; Valcárcel F; Sevilla N
PLoS One; 2015; 10(11):e0143273. PubMed ID: 26619062
[TBL] [Abstract][Full Text] [Related]
18. Generation of Recombinant Modified Vaccinia Virus Ankara Encoding VP2, NS1, and VP7 Proteins of Bluetongue Virus.
Marín-López A; Ortego J
Methods Mol Biol; 2016; 1349():137-50. PubMed ID: 26458834
[TBL] [Abstract][Full Text] [Related]
19. Protection of IFNAR (-/-) mice against bluetongue virus serotype 8, by heterologous (DNA/rMVA) and homologous (rMVA/rMVA) vaccination, expressing outer-capsid protein VP2.
Jabbar TK; Calvo-Pinilla E; Mateos F; Gubbins S; Bin-Tarif A; Bachanek-Bankowska K; Alpar O; Ortego J; Takamatsu HH; Mertens PP; Castillo-Olivares J
PLoS One; 2013; 8(4):e60574. PubMed ID: 23593251
[TBL] [Abstract][Full Text] [Related]
20. Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge.
Wade-Evans AM; Romero CH; Mellor P; Takamatsu H; Anderson J; Thevasagayam J; Fleming MJ; Mertens PP; Black DN
Virology; 1996 Jun; 220(1):227-31. PubMed ID: 8659119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
